Patent · US Active

Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseases

US11717560B2 · kind B2 · utility

0Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 11, 2021
Grant dateAug 8, 2023
Priority date
Expiry dateNov 11, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides nucleic acid expression cassettes, vectors, compositions and methods for the treatment of ATPase-mediated diseases in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.